Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06049225 · ClinicalTrials.gov registry record · NA

Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities

A NA study of Type 2 Diabetes and Physical Disability, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06049225 is a NA study of Type 2 Diabetes and Physical Disability that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 90 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06049225, a NA study of Type 2 Diabetes and Physical Disability, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to develop, and pilot test an accessible and inclusive medical nutrition therapy and diabetes self-management education program for people with Type 2 Diabetes and physical disabilities.

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL High-Tech
  • BEHAVIORAL Low-Tech

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-06-01
Est. Completion 2025-09-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06049225

The ClinicalTrials.gov registry entry for NCT06049225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Attention Control is the first listed.

NCT06049225 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06049225 about?

NCT06049225 is a clinical study titled "Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities". The purpose of this project is to develop, and pilot test an accessible and inclusive medical nutrition therapy and diabetes self-management education program for people with Type 2 Diabetes and physical disabilities.

What is the current status of trial NCT06049225?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2024-06-01. Estimated completion is 2025-09-01.

What conditions does trial NCT06049225 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Physical Disability.

What interventions are being tested in trial NCT06049225?

The interventions under investigation include: Attention Control (BEHAVIORAL), High-Tech (BEHAVIORAL), Low-Tech (BEHAVIORAL).

Who is sponsoring clinical trial NCT06049225?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06049225 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.